Global Newcastle Disease Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Global Newcastle Disease Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Table of Contents
1 Study Coverage
1.1 Newcastle Disease Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Newcastle Disease Vaccine Market Size Growth Rate by Type
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market by Application
1.3.1 Global Newcastle Disease Vaccine Market Size Growth Rate by Application
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Newcastle Disease Vaccine Market Size Estimates and Forecasts
2.1.1 Global Newcastle Disease Vaccine Revenue 2015-2026
2.1.2 Global Newcastle Disease Vaccine Sales 2015-2026
2.2 Newcastle Disease Vaccine Market Size by Region: 2020 Versus 2026
2.3 Newcastle Disease Vaccine Sales by Region (2015-2026)
2.3.1 Global Newcastle Disease Vaccine Sales by Region: 2015-2020
2.3.2 Global Newcastle Disease Vaccine Sales Forecast by Region (2021-2026)
2.3.3 Global Newcastle Disease Vaccine Sales Market Share by Region (2015-2026)
2.4 Newcastle Disease Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Newcastle Disease Vaccine Revenue by Region: 2015-2020
2.4.2 Global Newcastle Disease Vaccine Revenue Forecast by Region (2021-2026)
2.4.3 Global Newcastle Disease Vaccine Revenue Market Share by Region (2015-2026)
3 Global Newcastle Disease Vaccine by Manufacturers
3.1 Global Top Newcastle Disease Vaccine Manufacturers by Sales
3.1.1 Global Newcastle Disease Vaccine Sales by Manufacturer (2015-2020)
3.1.2 Global Newcastle Disease Vaccine Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Newcastle Disease Vaccine Manufacturers by Revenue
3.2.1 Global Newcastle Disease Vaccine Revenue by Manufacturer (2015-2020)
3.2.2 Global Newcastle Disease Vaccine Revenue Share by Manufacturer (2015-2020)
3.3 Global Newcastle Disease Vaccine Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Newcastle Disease Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Newcastle Disease Vaccine Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Newcastle Disease Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Newcastle Disease Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Newcastle Disease Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Newcastle Disease Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Merial
4.1.1 Merial Corporation Information
4.1.2 Merial Description, Business Overview
4.1.3 Merial Newcastle Disease Vaccine Products Offered
4.1.4 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Merial Newcastle Disease Vaccine Revenue by Product
4.1.6 Merial Newcastle Disease Vaccine Revenue by Application
4.1.7 Merial Newcastle Disease Vaccine Revenue by Geographic Area
4.1.8 Merial Newcastle Disease Vaccine Revenue by Sales Channel
4.1.9 Merial Recent Development
4.2 CEVA
4.2.1 CEVA Corporation Information
4.2.2 CEVA Description, Business Overview
4.2.3 CEVA Newcastle Disease Vaccine Products Offered
4.2.4 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.2.5 CEVA Newcastle Disease Vaccine Revenue by Product
4.2.6 CEVA Newcastle Disease Vaccine Revenue by Application
4.2.7 CEVA Newcastle Disease Vaccine Revenue by Geographic Area
4.2.8 CEVA Newcastle Disease Vaccine Revenue by Sales Channel
4.2.9 CEVA Recent Development
4.3 QYH Biotech
4.3.1 QYH Biotech Corporation Information
4.3.2 QYH Biotech Description, Business Overview
4.3.3 QYH Biotech Newcastle Disease Vaccine Products Offered
4.3.4 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.3.5 QYH Biotech Newcastle Disease Vaccine Revenue by Product
4.3.6 QYH Biotech Newcastle Disease Vaccine Revenue by Application
4.3.7 QYH Biotech Newcastle Disease Vaccine Revenue by Geographic Area
4.3.8 QYH Biotech Newcastle Disease Vaccine Revenue by Sales Channel
4.3.9 QYH Biotech Recent Development
4.4 Ringpu Biology
4.4.1 Ringpu Biology Corporation Information
4.4.2 Ringpu Biology Description, Business Overview
4.4.3 Ringpu Biology Newcastle Disease Vaccine Products Offered
4.4.4 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Ringpu Biology Newcastle Disease Vaccine Revenue by Product
4.4.6 Ringpu Biology Newcastle Disease Vaccine Revenue by Application
4.4.7 Ringpu Biology Newcastle Disease Vaccine Revenue by Geographic Area
4.4.8 Ringpu Biology Newcastle Disease Vaccine Revenue by Sales Channel
4.4.9 Ringpu Biology Recent Development
4.5 Yebio
4.5.1 Yebio Corporation Information
4.5.2 Yebio Description, Business Overview
4.5.3 Yebio Newcastle Disease Vaccine Products Offered
4.5.4 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Yebio Newcastle Disease Vaccine Revenue by Product
4.5.6 Yebio Newcastle Disease Vaccine Revenue by Application
4.5.7 Yebio Newcastle Disease Vaccine Revenue by Geographic Area
4.5.8 Yebio Newcastle Disease Vaccine Revenue by Sales Channel
4.5.9 Yebio Recent Development
4.6 Harbin Veterinary Research Institute
4.6.1 Harbin Veterinary Research Institute Corporation Information
4.6.2 Harbin Veterinary Research Institute Description, Business Overview
4.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Products Offered
4.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.6.5 Harbin Veterinary Research Institute Newcastle Disease Vaccine Revenue by Product
4.6.6 Harbin Veterinary Research Institute Newcastle Disease Vaccine Revenue by Application
4.6.7 Harbin Veterinary Research Institute Newcastle Disease Vaccine Revenue by Geographic Area
4.6.8 Harbin Veterinary Research Institute Recent Development
4.7 Merck Animal Health
4.7.1 Merck Animal Health Corporation Information
4.7.2 Merck Animal Health Description, Business Overview
4.7.3 Merck Animal Health Newcastle Disease Vaccine Products Offered
4.7.4 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.7.5 Merck Animal Health Newcastle Disease Vaccine Revenue by Product
4.7.6 Merck Animal Health Newcastle Disease Vaccine Revenue by Application
4.7.7 Merck Animal Health Newcastle Disease Vaccine Revenue by Geographic Area
4.7.8 Merck Animal Health Recent Development
4.8 DHN
4.8.1 DHN Corporation Information
4.8.2 DHN Description, Business Overview
4.8.3 DHN Newcastle Disease Vaccine Products Offered
4.8.4 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.8.5 DHN Newcastle Disease Vaccine Revenue by Product
4.8.6 DHN Newcastle Disease Vaccine Revenue by Application
4.8.7 DHN Newcastle Disease Vaccine Revenue by Geographic Area
4.8.8 DHN Recent Development
4.9 Zoetis
4.9.1 Zoetis Corporation Information
4.9.2 Zoetis Description, Business Overview
4.9.3 Zoetis Newcastle Disease Vaccine Products Offered
4.9.4 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.9.5 Zoetis Newcastle Disease Vaccine Revenue by Product
4.9.6 Zoetis Newcastle Disease Vaccine Revenue by Application
4.9.7 Zoetis Newcastle Disease Vaccine Revenue by Geographic Area
4.9.8 Zoetis Recent Development
4.10 ChengDu Tecbond
4.10.1 ChengDu Tecbond Corporation Information
4.10.2 ChengDu Tecbond Description, Business Overview
4.10.3 ChengDu Tecbond Newcastle Disease Vaccine Products Offered
4.10.4 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.10.5 ChengDu Tecbond Newcastle Disease Vaccine Revenue by Product
4.10.6 ChengDu Tecbond Newcastle Disease Vaccine Revenue by Application
4.10.7 ChengDu Tecbond Newcastle Disease Vaccine Revenue by Geographic Area
4.10.8 ChengDu Tecbond Recent Development
4.11 Elanco (Lohmann)
4.11.1 Elanco (Lohmann) Corporation Information
4.11.2 Elanco (Lohmann) Description, Business Overview
4.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Products Offered
4.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.11.5 Elanco (Lohmann) Newcastle Disease Vaccine Revenue by Product
4.11.6 Elanco (Lohmann) Newcastle Disease Vaccine Revenue by Application
4.11.7 Elanco (Lohmann) Newcastle Disease Vaccine Revenue by Geographic Area
4.11.8 Elanco (Lohmann) Recent Development
4.12 FATRO
4.12.1 FATRO Corporation Information
4.12.2 FATRO Description, Business Overview
4.12.3 FATRO Newcastle Disease Vaccine Products Offered
4.12.4 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.12.5 FATRO Newcastle Disease Vaccine Revenue by Product
4.12.6 FATRO Newcastle Disease Vaccine Revenue by Application
4.12.7 FATRO Newcastle Disease Vaccine Revenue by Geographic Area
4.12.8 FATRO Recent Development
4.13 CAVAC
4.13.1 CAVAC Corporation Information
4.13.2 CAVAC Description, Business Overview
4.13.3 CAVAC Newcastle Disease Vaccine Products Offered
4.13.4 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.13.5 CAVAC Newcastle Disease Vaccine Revenue by Product
4.13.6 CAVAC Newcastle Disease Vaccine Revenue by Application
4.13.7 CAVAC Newcastle Disease Vaccine Revenue by Geographic Area
4.13.8 CAVAC Recent Development
4.14 Vaksindo
4.14.1 Vaksindo Corporation Information
4.14.2 Vaksindo Description, Business Overview
4.14.3 Vaksindo Newcastle Disease Vaccine Products Offered
4.14.4 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.14.5 Vaksindo Newcastle Disease Vaccine Revenue by Product
4.14.6 Vaksindo Newcastle Disease Vaccine Revenue by Application
4.14.7 Vaksindo Newcastle Disease Vaccine Revenue by Geographic Area
4.14.8 Vaksindo Recent Development
5 Breakdown Data by Type
5.1 Global Newcastle Disease Vaccine Sales by Type (2015-2026)
5.1.1 Global Newcastle Disease Vaccine Sales by Type (2015-2020)
5.1.2 Global Newcastle Disease Vaccine Sales Forecast by Type (2021-2026)
5.1.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2015-2026)
5.2 Global Newcastle Disease Vaccine Revenue Forecast by Type (2015-2026)
5.2.1 Global Newcastle Disease Vaccine Revenue by Type (2015-2020)
5.2.2 Global Newcastle Disease Vaccine Revenue Forecast by Type (2021-2026)
5.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2015-2026)
5.3 Newcastle Disease Vaccine Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Newcastle Disease Vaccine Sales by Application (2015-2026)
6.1.1 Global Newcastle Disease Vaccine Sales by Application (2015-2020)
6.1.2 Global Newcastle Disease Vaccine Sales Forecast by Application (2021-2026)
6.1.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2015-2026)
6.2 Global Newcastle Disease Vaccine Revenue Forecast by Application (2015-2026)
6.2.1 Global Newcastle Disease Vaccine Revenue by Application (2015-2020)
6.2.2 Global Newcastle Disease Vaccine Revenue Forecast by Application (2021-2026)
6.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2015-2026)
6.3 Newcastle Disease Vaccine Average Selling Price (ASP) by Application (2015-2026)
7 North America
7.1 North America Newcastle Disease Vaccine Market Size YoY Growth 2015-2026
7.2 North America Newcastle Disease Vaccine Market Facts & Figures by Country
7.2.1 North America Newcastle Disease Vaccine Sales by Country (2015-2026)
7.2.2 North America Newcastle Disease Vaccine Revenue by Country (2015-2026)
7.3 North America Newcastle Disease Vaccine Sales by Type
7.4 North America Newcastle Disease Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Newcastle Disease Vaccine Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Newcastle Disease Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Newcastle Disease Vaccine Sales by Region (2015-2026)
8.2.2 Asia-Pacific Newcastle Disease Vaccine Revenue by Region (2015-2026)
8.3 Asia-Pacific Newcastle Disease Vaccine Sales by Type
8.4 Asia-Pacific Newcastle Disease Vaccine Sales by Application
9 Europe
9.1 Europe Newcastle Disease Vaccine Market Size YoY Growth 2015-2026
9.2 Europe Newcastle Disease Vaccine Market Facts & Figures by Country
9.2.1 Europe Newcastle Disease Vaccine Sales by Country (2015-2026)
9.2.2 Europe Newcastle Disease Vaccine Revenue by Country (2015-2026)
9.3 Europe Newcastle Disease Vaccine Sales by Type
9.4 Europe Newcastle Disease Vaccine Sales by Application
10 Latin America
10.1 Latin America Newcastle Disease Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Newcastle Disease Vaccine Market Facts & Figures by Country
10.2.1 Latin America Newcastle Disease Vaccine Sales by Country (2015-2026)
10.2.2 Latin America Newcastle Disease Vaccine Revenue by Country (2015-2026)
10.3 Latin America Newcastle Disease Vaccine Sales by Type
10.4 Latin America Newcastle Disease Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Newcastle Disease Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Newcastle Disease Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Newcastle Disease Vaccine Sales by Country (2015-2026)
11.2.2 Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2015-2026)
11.3 Middle East and Africa Newcastle Disease Vaccine Sales by Type
11.4 Middle East and Africa Newcastle Disease Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Newcastle Disease Vaccine Supply Chain Analysis
12.2 Newcastle Disease Vaccine Key Raw Materials and Upstream Suppliers
12.3 Newcastle Disease Vaccine Clients Analysis
12.4 Newcastle Disease Vaccine Sales Channel and Sales Model Analysis
12.4.1 Newcastle Disease Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Newcastle Disease Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Newcastle Disease Vaccine Distributors
13 Market Dynamics
13.1 Newcastle Disease Vaccine Market Drivers
13.2 Newcastle Disease Vaccine Market Opportunities
13.3 Newcastle Disease Vaccine Market Challenges
13.4 Newcastle Disease Vaccine Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Newcastle Disease Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Major Manufacturers of Live Vaccines
Table 3. Major Manufacturers of Killed Vaccines
Table 4. Global Newcastle Disease Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 5. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2026
Table 6. Global Newcastle Disease Vaccine Sales by Region (2015-2020) & (M Doses)
Table 7. Global Newcastle Disease Vaccine Sales Forecast by Region (2021-2026) & (M Doses)
Table 8. Global Newcastle Disease Vaccine Revenue by Region (2015-2020) & (US$ Million)
Table 9. Global Newcastle Disease Vaccine Revenue Forecast by Region (2021-2026) & (US$ Million)
Table 10. Global Newcastle Disease Vaccine Sales by Manufacturer (2015-2020) & (M Doses)
Table 11. Global Newcastle Disease Vaccine Sales Share by Manufacturer (2015-2020)
Table 12. Newcastle Disease Vaccine Revenue by Manufacturer (2015-2020) & (US$ Million)
Table 13. Newcastle Disease Vaccine Revenue Share by Manufacturer (2015-2020)
Table 14. Key Manufacturers Newcastle Disease Vaccine Price (2015-2020) & (USD/K Doses)
Table 15. Ranking of Global Top Newcastle Disease Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 16. Global Newcastle Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)
Table 17. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Newcastle Disease Vaccine as of 2019)
Table 18. Newcastle Disease Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Newcastle Disease Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Newcastle Disease Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Merial Corporation Information
Table 23. Merial Description and Business Overview
Table 24. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 25. Merial Newcastle Disease Vaccine Product
Table 26. Merial Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 27. Merial Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 28. Merial Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 29. Merial Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 30. Merial Recent Development
Table 31. CEVA Corporation Information
Table 32. CEVA Description and Business Overview
Table 33. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 34. CEVA Newcastle Disease Vaccine Product
Table 35. CEVA Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 36. CEVA Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 37. CEVA Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 38. CEVA Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 39. CEVA Recent Development
Table 40. QYH Biotech Corporation Information
Table 41. QYH Biotech Description and Business Overview
Table 42. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 43. QYH Biotech Newcastle Disease Vaccine Product
Table 44. QYH Biotech Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 45. QYH Biotech Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 46. QYH Biotech Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 47. QYH Biotech Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 48. QYH Biotech Recent Development
Table 49. Ringpu Biology Corporation Information
Table 50. Ringpu Biology Description and Business Overview
Table 51. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 52. Ringpu Biology Newcastle Disease Vaccine Product
Table 53. Ringpu Biology Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 54. Ringpu Biology Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 55. Ringpu Biology Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 56. Ringpu Biology Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 57. Ringpu Biology Recent Development
Table 58. Yebio Corporation Information
Table 59. Yebio Description and Business Overview
Table 60. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 61. Yebio Newcastle Disease Vaccine Product
Table 62. Yebio Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 63. Yebio Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 64. Yebio Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 65. Yebio Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 66. Yebio Recent Development
Table 67. Harbin Veterinary Research Institute Corporation Information
Table 68. Harbin Veterinary Research Institute Description and Business Overview
Table 69. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 70. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product
Table 71. Harbin Veterinary Research Institute Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 72. Harbin Veterinary Research Institute Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 73. Harbin Veterinary Research Institute Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 74. Harbin Veterinary Research Institute Recent Development
Table 75. Merck Animal Health Corporation Information
Table 76. Merck Animal Health Description and Business Overview
Table 77. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 78. Merck Animal Health Newcastle Disease Vaccine Product
Table 79. Merck Animal Health Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 80. Merck Animal Health Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 81. Merck Animal Health Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 82. Merck Animal Health Recent Development
Table 83. DHN Corporation Information
Table 84. DHN Description and Business Overview
Table 85. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 86. DHN Newcastle Disease Vaccine Product
Table 87. DHN Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 88. DHN Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 89. DHN Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 90. DHN Recent Development
Table 91. Zoetis Corporation Information
Table 92. Zoetis Description and Business Overview
Table 93. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 94. Zoetis Newcastle Disease Vaccine Product
Table 95. Zoetis Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 96. Zoetis Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 97. Zoetis Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 98. Zoetis Recent Development
Table 99. ChengDu Tecbond Corporation Information
Table 100. ChengDu Tecbond Description and Business Overview
Table 101. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 102. ChengDu Tecbond Newcastle Disease Vaccine Product
Table 103. ChengDu Tecbond Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 104. ChengDu Tecbond Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 105. ChengDu Tecbond Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 106. ChengDu Tecbond Recent Development
Table 107. Elanco (Lohmann) Corporation Information
Table 108. Elanco (Lohmann) Description and Business Overview
Table 109. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 110. Elanco (Lohmann) Newcastle Disease Vaccine Product
Table 111. Elanco (Lohmann) Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 112. Elanco (Lohmann) Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 113. Elanco (Lohmann) Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 114. Elanco (Lohmann) Recent Development
Table 115. FATRO Corporation Information
Table 116. FATRO Description and Business Overview
Table 117. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 118. FATRO Newcastle Disease Vaccine Product
Table 119. FATRO Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 120. FATRO Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 121. FATRO Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 122. FATRO Recent Development
Table 123. CAVAC Corporation Information
Table 124. CAVAC Description and Business Overview
Table 125. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 126. CAVAC Newcastle Disease Vaccine Product
Table 127. CAVAC Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 128. CAVAC Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 129. CAVAC Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 130. CAVAC Recent Development
Table 131. Vaksindo Corporation Information
Table 132. Vaksindo Description and Business Overview
Table 133. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 134. Vaksindo Newcastle Disease Vaccine Product
Table 135. Vaksindo Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Product
Table 136. Vaksindo Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Application
Table 137. Vaksindo Newcastle Disease Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 138. Vaksindo Recent Development
Table 139. Global Newcastle Disease Vaccine Sales by Type (2015-2020) & (M Doses)
Table 140. Global Newcastle Disease Vaccine Sales Forecast by Type (2021-2026) & (M Doses)
Table 141. Global Newcastle Disease Vaccine Revenue by Type (2015-2020) & (US$ Million)
Table 142. Global Newcastle Disease Vaccine Revenue Forecast by Type (2021-2026) & (US$ Million)
Table 143. Global Newcastle Disease Vaccine Sales by Application (2015-2020) & (M Doses)
Table 144. Global Newcastle Disease Vaccine Sales Forecast by Application (2021-2026) & (M Doses)
Table 145. Global Newcastle Disease Vaccine Revenue by Application (2015-2020) & (US$ Million)
Table 146. Global Newcastle Disease Vaccine Revenue Forecast by Application (2021-2026) & (US$ Million)
Table 147. North America Newcastle Disease Vaccine Sales by Country (2015-2020) & (M Doses)
Table 148. North America Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses)
Table 149. North America Newcastle Disease Vaccine Revenue by Country (2015-2020) & (US$ Million)
Table 150. North America Newcastle Disease Vaccine Revenue by Country (2021-2026) & (US$ Million)
Table 151. North America Newcastle Disease Vaccine Sales by Type (2015-2020) & (M Doses)
Table 152. North America Newcastle Disease Vaccine Sales by Application (2015-2020) & (M Doses)
Table 153. Asia-Pacific Newcastle Disease Vaccine Sales by Region (2015-2020) & (M Doses)
Table 154. Asia-Pacific Newcastle Disease Vaccine Sales by Region (2021-2026) & (M Doses)
Table 155. Asia-Pacific Newcastle Disease Vaccine Revenue by Region (2015-2026) & (US$ Million)
Table 156. Asia-Pacific Newcastle Disease Vaccine Revenue by Region (2021-2026) & (US$ Million)
Table 157. Asia-Pacific Newcastle Disease Vaccine Sales by Type (2015-2020) & (M Doses)
Table 158. Asia-Pacific Newcastle Disease Vaccine Sales by Application (2015-2020) & (M Doses)
Table 159. Europe Newcastle Disease Vaccine Sales by Country (2015-2020) & (M Doses)
Table 160. Europe Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses)
Table 161. Europe Newcastle Disease Vaccine Revenue by Country (2015-2020) & (US$ Million)
Table 162. Europe Newcastle Disease Vaccine Revenue by Country (2021-2026) & (US$ Million)
Table 163. Europe Newcastle Disease Vaccine Sales by Type (2015-2020) & (M Doses)
Table 164. Europe Newcastle Disease Vaccine Sales by Application (2015-2020) & (M Doses)
Table 165. Latin America Newcastle Disease Vaccine Sales by Country (2015-2020) & (M Doses)
Table 166. Latin America Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses)
Table 167. Latin America Newcastle Disease Vaccine Revenue by Country (2015-2020) & (US$ Million)
Table 168. Latin America Newcastle Disease Vaccine Revenue by Country (2021-2026) & (US$ Million)
Table 169. Latin America Newcastle Disease Vaccine Sales by Type (2015-2020) & (M Doses)
Table 170. Latin America Newcastle Disease Vaccine Sales by Application (2015-2020) & (M Doses)
Table 171. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2015-2020) & (M Doses)
Table 172. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses)
Table 173. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2015-2020) & (US$ Million)
Table 174. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2021-2026) & (US$ Million)
Table 175. Middle East and Africa Newcastle Disease Vaccine Sales by Type (2015-2020) & (M Doses)
Table 176. Middle East and Africa Newcastle Disease Vaccine Sales by Application (2015-2020) & (M Doses)
Table 177. Newcastle Disease Vaccine Key Raw Materials, Industry Status and Trend
Table 178. Newcastle Disease Vaccine Key Raw Materials and Upstream Suppliers
Table 179. Newcastle Disease Vaccine Clients Status and Trend
Table 180. Newcastle Disease Vaccine Typical Clients
Table 181. Newcastle Disease Vaccine Distributors
Table 182. Key Drivers: Impact Analysis (2021-2026)
Table 183. Newcastle Disease Vaccine Market Drivers
Table 184. Newcastle Disease Vaccine Market Opportunities
Table 185. Newcastle Disease Vaccine Market Challenges
Table 186. Newcastle Disease Vaccine Market Restraints
Table 187. Newcastle Disease Vaccine Porter's Five Forces Analysis
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Live Vaccines Product Picture
Figure 4. Killed Vaccines Product Picture
Figure 5. Global Newcastle Disease Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Chicken Examples
Figure 7. Duck & Goose Examples
Figure 8. Other Examples
Figure 9. Newcastle Disease Vaccine Report Years Considered
Figure 10. Global Newcastle Disease Vaccine Market Size, (US$ Million), 2015 VS 2020 VS 2026
Figure 11. Global Newcastle Disease Vaccine Market Size 2015-2026 (US$ Million)
Figure 12. Global Newcastle Disease Vaccine Sales 2015-2026 (K Units)
Figure 13. Global Newcastle Disease Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Newcastle Disease Vaccine Sales Market Share Forecast by Region (2015-2026)
Figure 15. Global Newcastle Disease Vaccine Revenue Market Share by Region (2015-2026)
Figure 16. Global Newcastle Disease Vaccine Sales Share by Manufacturer in 2019
Figure 17. Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Newcastle Disease Vaccine Sales Market Share Forecast by Type (2015-2026)
Figure 19. Global Newcastle Disease Vaccine Revenue Market Share Forecast by Type (2015-2026)
Figure 20. Newcastle Disease Vaccine Average Selling Price (ASP) by Type (2015-2020) & (USD/Unit)
Figure 21. Global Newcastle Disease Vaccine Sales Market Share Forecast by Application (2015-2026)
Figure 22. Global Newcastle Disease Vaccine Revenue Market Share Forecast by Application (2015-2026)
Figure 23. Newcastle Disease Vaccine Average Selling Price (ASP) by Application (2015-2020) & (USD/Unit)
Figure 24. North America Newcastle Disease Vaccine Revenue 2015-2026 (US$ Million)
Figure 25. North America Newcastle Disease Vaccine Sales Market Share by Type (2015-2020)
Figure 26. North America Newcastle Disease Vaccine Sales Market Share by Application (2015-2020)
Figure 27. Asia-Pac

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Classical Swine Fever Vaccines Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......

Global Tylosin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......

Global Animal Parasiticides Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......

Global Newcastle Disease Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......

Global Classical Swine Fever Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126

According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......

Global Veterinary Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......

Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......

Global Veterinary Products for Companion Animals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......

Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115

According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs